Show Notes
GenFlow Biosciences is a biotechnology company dedicated to increasing our understanding of the factors that controls lifespan. We research, develop and commercialize therapeutic solutions to lengthen healthspan, the amount of time we live in good health. Our mission is to create biological interventions that enable longer and healthier lives.
GENFLOW is dedicated to the development and commercialization of novel therapeutics targeting ageing in dogs and humans. Ageing is not a natural fatality.
There is no rationale for a limited lifespan. Ageing can now be considered as a risk factor that we can treat. By treating ageing, we believe that GENFLOW can contribute to decrease healthcare costs and lessen the emotional and societal burden that comes with an ageing population.
https://www.share-talk.com/eric-leire-chief-executive-officer-genflow-biosciences-interview/
https://www.share-talk.com/eric-leire-chief-executive-officer-genflow-biosciences-interview/
Listen On
Also Listen
-
Altona Rare Earths PLC (LON:REE) Dr Cedric Simonet spoke with Share Talk
Share Talk interviews Cédric Simonet, CEO of Altona Rare Earths (LON: REE), to d -
Zak Mir talking to Eddie Wyvill, head of Corporate Development – Amaroq Minerals Ltd.
Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine dev -
Zak Mir talking with Nick Tulloch, Chief Executive Officer of Mendell Helium
Zak Mir interviewed Mendell Helium CEO Nick Tulloch regarding M3Helium's new far -
ECR Minerals (AIM:ECR) Chairman Nick Tulloch, MD Mike Whitlow, Technical Consultant Mike Parker and Director Andrew Scott
ECR Minerals, a gold exploration company with assets in Australia, is making sig